JMCP February 2025 Issue

In this Issue

Research

Comparing demographic/clinical characteristics, health care resource utilization, and costs among patients with type 2 diabetes and established atherosclerotic cardiovascular disease with and without the use of cardioprotective medications
TJ Dunn, Y Cao, L Xie, M Guevarra, J Mitri

Addition of continuous glucose monitoring to glucagon-like peptide 1 receptor agonist treatment for type 2 diabetes mellitus – An economic evaluation
EE Wright, E Miller, A Bindal, Y Poon

Cost-effectiveness of cemiplimab plus chemotherapy 
vs pembrolizumab plus chemotherapy as first-line treatment for advanced non–small cell lung cancer
X Xue, S Ngorsuraches, B Johnson, J Zheng, J Qian

Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey
MG Bowles, AD Zuckerman, J DeClercq, L Choi,

M Ellis, CP Renfro

Patient characteristics and use for bevacizumab 
in ophthalmology and oncology in a distributed 
research network
JS Ko, AB Mendelsohn, K Daniels, A Gomez-Lumbreras,

J Marshall, C McDermott, PA Pawloski, GC Yee, CM Lockhart

Antidepressant adherence using group-based trajectory modeling among postpartum women with Texas Medicaid
EL Pennington, JC Barner, CM Brown, LR Moczygemba,

DA Patel, TJ Varisco

Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States
K Ezendu, G Pohl, CJ Lee, H Wang, X Li, JP Dunn

Pharmacist vs physician management of e-visit requests 
for COVID-19 medication: A randomized clinical trial
TA Lieu, EM Warton, A deLaunay, S Prausnitz, M Chan,

MR Mancha, T Huynh, E Smallberg, C Quesenberry,

K Lee, M Reed

Viewpoint

Call for the alignment of Medicare Part D formularies with clinical treatment guidelines for asthma

A Lao, A McNamara, LLS Chan, D Smith
 

Racial and Social Disparities in Medication Use 

Real-world treatment and health care utilization 
among patients with Duchenne muscular dystrophy by race and ethnicity in a Medicaid population
N Posner, J Manjelievskaia, AK Talaga, M Richards, CR Lew,

V Merla, JMJ Alvir, SF Nelson

Pharmacoequity measurement framework: A tool to reduce health disparities
PM Patel, UR Essien, L Happe

LETTER TO THE EDITOR

Real-world evidence: A new era is upon us
BT Sweet

CORRECTION

Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2− metastatic breast cancer treated with a CDK4/6i in the first-line setting
E Behan, DL Veenstra, A Bansal

COMPLETE ISSUE 

JMCP, February 2025, Volume 31, Number 2 

SUPPLEMENTS IN THIS ISSUE

Emerging Trends in Managed Care Pharmacy

OUTSERTS IN THIS ISSUE